Telesis Bio

Telesis Bio

  • Founded: 2013
  • Location: San Diego, CA
  • Employee range: 50 - 200
  • Funding: $28M stock Jun 2023; $123M IPO Jun 2021; $25M A Sep 2019

job board

Short description:

Synthetic DNA

Drug notes:

Contact us to add description:

Long description:

Telesis Bio is creating technology that gives researchers end-to-end solutions to design, code and create synthetic DNA. Novel synthetic biology solutions depend upon the ability to rapidly, accurately and reproducibly write DNA or RNA for various downstream applications. Telesis has created technology, using advances in DNA assembly, to overcome these bottlenecks in synthetic biology workflows. Led by a diverse team of scientists and engineers, including Dr. Dan Gibson, who invented the Gibson Assembly method®, Telesis has already created the world’s first DNA printer, the BioXpTM 3250 and the first synthetic flu vaccine. With these technologies, Telesis plays a role in accelerating advances in fields of personalized medicine to gene therapy.


© 2024 Work In Biotech LLC
Personal data

Terms of Service

Privacy Policy